Home  »  News   »  Galera Therapeutics Inc.’s Banking’s 100-D...

Galera Therapeutics Inc.’s Banking’s 100-Day Moving Average at 2.1518: Will the Stock Break Through?

Galera Therapeutics Inc. (GRTX) currently has a stock price of $0.22. The stock saw a sharp increase in the last trading session, hitting a high of $0.2017 after opening at $0.2017. The lowest recorded price for the day was $0.1886 before it closed at $0.19.

The market performance of Galera Therapeutics Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.59 on 06/13/23, with the lowest value for the same timeframe being $0.19, recorded on 09/15/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of GRTX Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Galera Therapeutics Inc.’s current trading price is -93.85% away from its 52-week high, while its distance from the 52-week low is 18.65%. The stock’s price range during this period has fluctuated between $0.19 and $3.59. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 27.61 million for the day, which was evidently higher than the average daily volume of 2.61 million over the last three months.

Financial Performance and Market Capitalization

Galera Therapeutics Inc. (GRTX) has experienced a quarterly decline of -92.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.81M and boasts a workforce of 31 employees.

Analysts’ Ratings For Galera Therapeutics Inc.

As of right now, 4 analysts are rating Galera Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.1518, with a change in price of -2.5445. Similarly, Galera Therapeutics Inc. recorded 2,139,147 in trading volume during the last 100 days, posting a change of -92.03%.

GRTX Stock Stochastic Average

Galera Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 1.19%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 61.94%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 24.08% and 11.41%, respectively.

GRTX Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -85.19%.However, over the last six months, we can see a stronger performance of -89.92%. Over the last 30 days, the price of GRTX has leaped by -0.28%. And in the last five days, it has surged by 13.29%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts